Amylyx Pharmaceuticals, Inc.
Amylyx Pharmaceuticals, Inc. (AMLX) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
amlx · stock forecast · 11 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 11 Wall Street analysts in the past 3 months
Buy
11 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$34.00
Consensus
$27.50
+114.0% upside
Low
$21.00
Median: $27.5 · Last Close: $12.85
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$27.50
114.0% upside
High Target
$34
164.5%
Low Target
$21
63.4%
Current Price
$12.85
as of today
Based on analyst price targets, the AMLX stock price prediction for the next 12 months ranges from $21 to $34. The consensus AMLX price forecast of $27.50 implies 114.0% upside from the current price of $12.85.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $12.61 | ↓ 1.85% |
1-day model range: $12.53–$12.7. Peak: $12.7 (-1.85%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $22 | +67.5% |
| 2028 | $30 | +129.6% |
| 2029 | $36 | +176.5% |
| 2030 | $40 | +207.6% |
| 2031 | — | +226.6% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · AMLX · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-28 | Mizuho | Maintains | Outperform→Outperform |
| 2026-03-25 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-19 | Guggenheim | Maintains | Buy→Buy |
| 2026-03-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-20 | B of A Securities | Maintains | Buy→Buy |
| 2026-02-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-11-07 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-10-17 | Citigroup | Maintains | Buy→Buy |
| 2025-10-16 | Baird | Maintains | Outperform→Outperform |
| 2025-10-03 | B of A Securities | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Amylyx Pharmaceuticals, Inc. (AMLX) stock. Of the recent 64 rating actions, 4 were upgrades and 5 were downgrades. 11 analysts currently cover AMLX.
Analyst Recommendation Trends
AMLX analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$0M
↓ 99.9% YoY
Revenue Next Year
$45M
↑ 55323.5% YoY
EPS This Year
$-1.41
EPS Next Year
$-1.27
↓ 9.9% YoY
EPS ForecastReported vs Estimated
Analysts forecast AMLX EPS of $-1.41 for the current fiscal year, based on estimates from 7 analysts. The AMLX revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The AMLX stock forecast is supported by two independent data sources: analyst consensus ratings from 11 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus AMLX price target is $27.50 (+114.0% upside), with an analyst consensus of Buy.
The AMLX short-term stock prediction for tomorrow is $12.61 (-1.85%). The AMLX stock price prediction for 2027 estimates an average of $22. The AMLX stock prediction for 2030 projects a range of $37–$42.
Amylyx Pharmaceuticals, Inc. trades on NASDAQ under the ticker AMLX. The AMLX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 91% of covering analysts.
Frequently asked questions
AMLX forecast · 8 questionsAccording to 11 Wall Street analysts, the average 12-month AMLX price target is $27.50, with a high forecast of $34.00 and a low of $21.00. The median price target is shown in the chart above when available. This implies +114.0% potential upside from the current price of $12.85.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.